Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin with Bladder Training for OAB
NCT00337558Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- May 2006
- Primary completion
- May 2007
- Modality
- Orthosteric Ligands
- Countries
- 11
01
Overview
A Phase 4 trial of solifenacin in overactive bladder (OAB), sponsored by Astellas Pharma. Started May 2006; status: completed.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00337558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00337558.